Sprint Bioscience Management
Management criteria checks 3/4
Sprint Bioscience's CEO is Johan Emilsson, appointed in Oct 2023, has a tenure of 1.17 years. total yearly compensation is SEK1.68M, comprised of 25% salary and 75% bonuses, including company stock and options. directly owns 0.029% of the company’s shares, worth SEK31.65K. The average tenure of the management team and the board of directors is 3.3 years and 4.9 years respectively.
Key information
Johan Emilsson
Chief executive officer
SEK 1.7m
Total compensation
| CEO salary percentage | 25.0% |
| CEO tenure | 1.2yrs |
| CEO ownership | 0.03% |
| Management average tenure | 3.3yrs |
| Board average tenure | 4.9yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -SEK 19m |
| Jun 30 2024 | n/a | n/a | SEK 15m |
| Mar 31 2024 | n/a | n/a | SEK 9m |
| Dec 31 2023 | SEK 2m | SEK 420k | -SEK 438k |
Compensation vs Market: Johan's total compensation ($USD152.20K) is below average for companies of similar size in the Swedish market ($USD231.51K).
Compensation vs Earnings: Insufficient data to compare Johan's compensation with company performance.
CEO
Johan Emilsson (40 yo)
1.2yrs
Tenure
SEK 1,680,000
Compensation
Mr. Johan Emilsson is Chief Executive Officer of Sprint Bioscience AB (publ) since October 01, 2023. He has broad experience in business development within the pharmaceutical industry and most recently fro...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 1.2yrs | SEK 1.68m | 0.029% SEK 31.6k | |
| Founder | no data | SEK 25.00k | 0.91% SEK 1.0m | |
| Co-Founder & Chief Scientific Officer | 15.9yrs | no data | 0.39% SEK 433.1k | |
| Founder & Director of Structural Chemistry | no data | no data | no data | |
| Chief Financial Officer | 3.3yrs | no data | 0.10% SEK 113.9k | |
| Chief Business Officer | no data | no data | 0.26% SEK 281.7k |
3.3yrs
Average Tenure
53yo
Average Age
Experienced Management: SPRINT's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 4.9yrs | SEK 150.00k | 0.064% SEK 71.2k | |
| Independent Chairman of the Board | 3.9yrs | SEK 300.00k | 1.26% SEK 1.4m | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Director | 14.9yrs | SEK 150.00k | 15.13% SEK 16.7m | |
| Independent Director | 5.6yrs | SEK 150.00k | 0.072% SEK 79.1k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 1.6yrs | SEK 88.00k | no data |
4.9yrs
Average Tenure
61.5yo
Average Age
Experienced Board: SPRINT's board of directors are considered experienced (4.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 11:23 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sprint Bioscience AB (publ) is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Siri Ladow | Danske Bank |
| Christian Binder | Redeye |
| Johan Unnerus | Redeye |